These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 27465590)

  • 1. Last gasps of the hepatitis C virus dragon: Direct acting antiviral failures and hepatitis C virus-positive donors.
    Berenguer M
    Liver Transpl; 2016 Nov; 22(S1):47-51. PubMed ID: 27465590
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.
    Abdelqader A; Kabacam G; Woreta TA; Hamilton JP; Luu H; Al Khalloufi K; Saberi B; Philosophe B; Cameron AM; Gurakar A
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):1-5. PubMed ID: 28260422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of hepatitis C virus-associated membranoproliferative glomerulonephritis with direct-acting antiviral therapy after liver transplantation.
    Okamura K; Kuwabara T; Enoki H; Kohda Y; Adachi M; Hayashida S; Inomata Y; Mukoyama M
    Nephrology (Carlton); 2019 Nov; 24(11):1198-1199. PubMed ID: 31033081
    [No Abstract]   [Full Text] [Related]  

  • 4. Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.
    Coilly A; Samuel D
    J Hepatol; 2016 Jan; 64(1):226-31. PubMed ID: 26375245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Hepatitis C Antibodies Without Viral Transmission in Hepatitis C-Negative Recipients Receiving Kidneys From Hepatitis C-Positive Donors Treated With Direct-Acting Antiviral Therapy.
    Agarwal N; Davis RJ; Gracey DM; Wong G; Kable K; Wong JKW; Nankivell BJ; Strasser S; Wyburn K
    Transplantation; 2018 Mar; 102(3):e121-e122. PubMed ID: 29166337
    [No Abstract]   [Full Text] [Related]  

  • 6. Causes of treatment failure for hepatitis C in the era of direct-acting antiviral therapy.
    Cabezas J; Llerena S; Puente Á; Fábrega E; Crespo J
    Rev Esp Enferm Dig; 2016 Jul; 108(7):421-30. PubMed ID: 26666379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral treatment of recurrent hepatitis C after liver transplantation: the need for a multifaceted approach.
    Samuel D
    Hepatology; 2005 Mar; 41(3):436-8. PubMed ID: 15723322
    [No Abstract]   [Full Text] [Related]  

  • 8. Change of liver transplantation list composition: Pre versus post direct-acting antivirals era. The Niguarda Hospital experience.
    Viganò R; Mazzarelli C; Alberti AB; Perricone G
    Dig Liver Dis; 2017 Mar; 49(3):317. PubMed ID: 28174002
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment for hepatitis C before and after liver transplantation].
    Ueda Y; Marusawa H
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():306-10. PubMed ID: 26845950
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
    Fontana M; Ciuffreda D; Moradpour D; Pascual M
    Transplantation; 2007 Feb; 83(4):525-6. PubMed ID: 17318091
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of hepatitis C virus in the transplant patient.
    Berenguer M
    Clin Liver Dis; 2007 May; 11(2):355-76. PubMed ID: 17606212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C Virus Therapy for Decompensated and Posttransplant Patients.
    Dailey F; Ayoub WS
    J Clin Gastroenterol; 2017 Mar; 51(3):215-222. PubMed ID: 28178089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is splenectomy a cause of antiviral treatment failure in hepatitis C virus infection?
    Paraná R; Codes L; Andrade Z
    Hepatology; 2001 May; 33(5):1340. PubMed ID: 11343268
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon.
    Belga S; Doucette KE
    World J Gastroenterol; 2016 Jan; 22(4):1650-63. PubMed ID: 26819530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches to treatment of recurrent hepatitis C virus following liver transplantation using ribavirin.
    Bizollon T; Adahm M; Ducerf C; Baulieux J; Trepo C
    Transplant Proc; 1996 Oct; 28(5):2842-3. PubMed ID: 8908092
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Singh N; Dies D; Samant H
    Transplantation; 2017 May; 101(5):e192. PubMed ID: 28437390
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.
    Selzner N; Renner EL; Selzner M; Adeyi O; Kashfi A; Therapondos G; Girgrah N; Herath C; Levy GA; Lilly L
    Transplantation; 2009 Nov; 88(10):1214-21. PubMed ID: 19935376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
    Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
    Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus and liver transplantation: where do we stand?
    Burra P; De Martin E; Zanetto A; Senzolo M; Russo FP; Zanus G; Fagiuoli S
    Transpl Int; 2016 Feb; 29(2):135-52. PubMed ID: 26199060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I favor therapy for hepatitis C virus recurrence after transplantation.
    Samuel D
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S55-8. PubMed ID: 12362300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.